Key statistics
As of last trade Harmony Biosciences Holdings Inc (HRMY:NMQ) traded at 38.85, -2.21% below its 52-week high of 39.73, set on Sep 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.99 |
---|---|
High | 39.22 |
Low | 38.65 |
Bid | 38.78 |
Offer | 38.92 |
Previous close | 38.99 |
Average volume | 420.82k |
---|---|
Shares outstanding | 56.83m |
Free float | 33.36m |
P/E (TTM) | 19.96 |
Market cap | 2.22bn USD |
EPS (TTM) | 1.95 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 15:32 BST.
More ▼
- Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
- Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
- Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
- Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results